First Trust Amex Biotechnology Index
ETF was Monday's best performer, rising 3.2% after component
( MYOG) agreed to be bought by
Other biotech-related ETFs were also higher. The
ETF was gaining 1.3% to $46.14. The
PowerShares Dynamic Biotech & Genome
ETF was adding 1% to $16.91.
ETF was lower by nearly 1% as holding Gilead dropped 6.7%.
B2B Internet HOLDRs
( BHH) ETF was also stronger as
( ARBA) jumped 1.6%. The B2B Internet HOLDRs was gaining 4 cents to $2.27.
ETFs related to housing construction were also rising as the pending home sales index rose 4.3%, according to the National Association of Realtors. Among individual names,
was up 1.7%, and
was tacking on 1%.
ETF was higher by 46 cents, or 1.4%, to $33.18. The
iShares Dow Jones U.S. Home Construction
ETF was adding 32 cents, or 0.9%, $37.32.
Among losers, the
ETF was slumping 1%. Holdings
Check Point Software
were all falling by 2.7%. The Software HOLDRs was off 35 cents to $38.34.
iShares Dow Jones U.S. Brokers & Dealers
ETF was also lower as holding
Chicago Mercantile Exchange Holdings
slipped 2.7%. The ETF was down 39 cents, or 0.8%, to $48.98.